Northwest Biotherapeutics reported -123991000 in Equity Capital and Reserves for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Applied Genetic Technologies AGTC:US $ 47.03M 4.46M
AstraZeneca AZN:LN 39268M 476M
Celldex Therapeutics CLDX:US $ 398.1M 21.38M
Cytori Therapeutics CYTX:US $ 14.64M 3.81M
Cytrx CYTR:US 3.28M 1.5M
Eisai 4523:JP Y 734788M 4452M
Mirati Therapeutics MRTX:US $ 1249.28M 147.76M
Northwest Biotherapeutics NWBO:US -123991000 177.74M